Summertime - Order your personal cocktail of ... biomarkers!
Summertime is not over yet...!
Choose or Design your Perfect Cocktail of Biomarkers
Loading
Summertime is not over yet...!
Choose or Design your Perfect Cocktail of Biomarkers
Whether in infectious diseases (COVID-19, Sepsis, Zika), immuno-oncology, auto-immune, inflammatory disorders, evaluating innovative immunotherapies (ICPI) or cell therapies (CAR-T cells), uncontrolled release of cytokines, known as cytokine storm, may be life-threatening for patients. Detecting harmful levels of cytokines is a matter of life or death for patients, and crucial for adapting patient care.
As an expert in soluble biomarker analysis, ABL is a partner of choice to support you overcome these challenges.
Discover the Ella system:
- Fully automated fluidic immunoassay platform
- Validated standard curve included within the cartridge
- Multi-analytes possible with NO multiplexing: up to 8 analytes can be analyzed seperately limitating antibody cross-reactivity
- Sub-picogram level sensitivity, 4+ logs of dynamic range and high reproducibility
- Very low sample volume: 2.5 to 25 µL per duplicate and triplicate
- Customizable cartridges for building your own assays
- High throughput : up to ~300 samples a day
- Extended catalogue: 190+ soluble mediators available
Is this time unprecedented, unpredictable, scary ? Yes but
Leverage the robustness of MSD Multi-array® technology to get SENSITIVE and RELIABLE RESULTS for your BIOMARKER and IMMUNOGENICITY assays!
Contact us to learn more about MSD technology and our full suite of services.